Stayble Therapeutics AB 4K4.SG
Stayble Therapeutics AB. Stock Analysis 4K4.SG
Germany Health Care Nano Cap Stayble Therapeutics AB engages in the development of pharmaceutical products. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2020-03-09. The solutions are offered to the patients whose back pain persists after physiotherapy and drugs. The injection is given once and the effect is expected to remain throughout the patient's life and requires minimal rehabilitation. Main focus of the Company is to develop STA363 as a new way of treatment for patients suffering from chronic disc-related low back pain. STA363 focuses on the two primary causes of pain in degenerative disc disease: leakage of inflammatory substances and disc instability. The mechanism of action of the treatment is to stabilize the disk segment and eliminate the possibility of disk leakage.
Stayble Therapeutics AB (4K4.SG) Chart
Financial Metrics & Statements of Stayble Therapeutics AB (4K4.SG)
FAQ's for Stayble Therapeutics AB (4K4.SG)
- As of August 2026, Stayble Therapeutics AB 4K4.SG is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Stayble Therapeutics AB using these criteria to determine its compliance status.
- Muslim investors may consider investing in Stayble Therapeutics AB if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Stayble Therapeutics AB by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Stayble Therapeutics AB may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Stayble Therapeutics AB on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Stayble Therapeutics AB (4K4.SG)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
